CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 5 incoming connections
- ScaleRevenue is $33.48B, higher than 95% of all stocks globally
- FinancialsAltman Z-Score 0.59: distress zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
5.99%Above 5Y avg (2.56%)
Annual Rate
CNY 0.40Paid annual
Payout Ratio
37.5%Sustainable
Payback Period
17.0 yr
Last Ex-Dividend
Jul 3, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
104.86BCNY15.55B · vs all stocks (USD)
Trailing P/E
9.57xRevenue (TTM)
225.74BCNY33.48B · vs all stocks (USD)
Profit Margin
6.17%Beta
0.7010xvs all stocks
52-Week Change
-8.49%vs all stocks
Market Capitalization
104.86BCNY15.55B · vs all stocks (USD)
Enterprise Value
494.30BCNY73.31B · vs all stocks (USD)
Trailing P/E
9.57xForward P/E
8.30xPrice to Sales (TTM)
0.4791xPrice to Book (MRQ)
1.54xEnterprise to Revenue
2.19xEnterprise to EBITDA
8.70xGross Margin
19.52%Profit Margin
6.17%Operating Margin
15.26%Return on Assets (TTM)
3.08%Return on Equity (TTM)
9.14%Revenue (TTM)
225.74BCNY33.48B · vs all stocks (USD)
Revenue per Share (TTM)
14.49CNYUpdated Aug 19, 2026Quarterly Revenue Growth
-5.90%Gross Profit (TTM)
41.86BCNY6.21B · vs all stocks (USD)
EBITDA (TTM)
31.76BCNY4.71B · vs all stocks (USD)
Net Income (TTM)
11.15BCNY1.65B · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-9.80%Operating Cash Flow (TTM)
62.25BCNY9.23B · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-15.33BCNY-2.27B · vs all stocks (USD)
Trailing Annual Dividend Rate
0.4000CNYUpdated Aug 19, 2026Trailing Annual Dividend Yield
5.99%vs all stocks
5-Year Average Dividend Yield
2.56%vs all stocks
Payout Ratio
37.50%Minority Interest (Equity)
70.05BCNYFY2025 · Dec 31, 2025Revenue
229.29BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
186.99BCNYFY2025 · Dec 31, 2025Gross Profit
42.30BCNYFY2025 · Dec 31, 2025Operating Income
31.36BCNY4.65B · vs all stocks (USD)
Pre-tax Income
23.64BCNYFY2025 · Dec 31, 2025Income Tax Expense
4.14BCNYFY2025 · Dec 31, 2025Net Income
19.51BCNYFY2025 · Dec 31, 2025EBIT
30.72BCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
60.16BCNYFY2025 · Dec 31, 2025Research & Development
1.92BCNYFY2025 · Dec 31, 2025Selling, General & Administrative
1.70BCNYFY2025 · Dec 31, 2025Other Operating Expenses
2.76BCNYFY2025 · Dec 31, 2025Non-operating Interest Income
354.58MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
7.08BCNYFY2025 · Dec 31, 2025Net Income from Continuing Operations
19.51BCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-5.10BCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
31.91BCNYFY2025 · Dec 31, 2025Free Cash Flow
-25.64BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
18.05BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
19.51BCNYFY2025 · Dec 31, 2025Other Non-cash Items
7.04BCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
2.39BCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
2.98BCNYFY2025 · Dec 31, 2025Capital Expenditures
-57.55BCNYFY2025 · Dec 31, 2025Net Acquisitions
9.60MCNYFY2025 · Dec 31, 2025Purchase of Investments
-376.38MCNYFY2025 · Dec 31, 2025Sale of Investments
631.75MCNYFY2025 · Dec 31, 2025Other Investing Activity
-6.85MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-57.29BCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
181.38BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-172.05BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-14.84BCNYFY2025 · Dec 31, 2025Other Financing Charges
-2.57BCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-8.08BCNYFY2025 · Dec 31, 2025Shares Outstanding
15.70BSharesUpdated Aug 19, 2026Float Shares
7.55BSharesUpdated Aug 19, 2026% Held by Insiders
72.01%vs all stocks
% Held by Institutions
8.71%vs all stocks
Total Cash (MRQ)
21.73BCNY3.22B · vs all stocks (USD)
Total Cash per Share (MRQ)
1.39CNYUpdated Aug 19, 2026Total Debt (MRQ)
335.39BCNY49.74B · vs all stocks (USD)
Total Debt to Equity (MRQ)
1.62xCurrent Ratio (MRQ)
0.5170xBook Value per Share (MRQ)
4.46CNYUpdated Aug 19, 2026Total Assets
611.79BCNY90.73B · vs all stocks (USD)
Total Current Assets
91.47BCNYFY2025 · Dec 31, 2025Total Liabilities
399.27BCNYFY2025 · Dec 31, 2025Total Non-current Assets
520.32BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
224.49BCNYFY2025 · Dec 31, 2025Total Current Liabilities
174.78BCNYFY2025 · Dec 31, 2025Cash
4.92BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
19.46BCNYFY2025 · Dec 31, 2025Accounts Receivable
46.26BCNYFY2025 · Dec 31, 2025Inventory
11.00BCNYFY2025 · Dec 31, 2025Accounts Payable
21.30BCNYFY2025 · Dec 31, 2025Short-term Debt
93.91BCNYFY2025 · Dec 31, 2025Other Current Liabilities
12.51BCNYFY2025 · Dec 31, 2025Long-term Debt
214.98BCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
4.56BCNYFY2025 · Dec 31, 2025Common Stock (Book)
15.70BCNYFY2025 · Dec 31, 2025Retained Earnings
24.01BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
212.52BCNY31.52B · vs all stocks (USD)
52-Week Low
6.62CNYUpdated Aug 19, 202652-Week High
9.76CNYUpdated Aug 19, 202652-Week Change
-8.49%vs all stocks
Beta
0.7010xvs all stocks
50-Day MA
7.31CNYUpdated Aug 19, 2026200-Day MA
7.44CNYUpdated Aug 19, 2026Avg 10-Day Volume
89.62MSharesUpdated Aug 19, 2026Avg 30-Day Volume
124.68MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
0.7200CNYUpdated Aug 19, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 0.59: distress zoneCritical
Altman Z-Score: 0.59
High earnings qualityNotable
Earnings Quality Score: 1.10
Supply Chain
Midstream position: 6 outgoing, 5 incoming connectionsNotable
Outgoing: 6.00Incoming: 5.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Scale
Revenue is $33.48B, higher than 95% of all stocks globallySignificant
Revenue (USD): 33,476,609,848.115Global P95: 15,102,391,082.578
Levered free cash flow is -$2.27B, lower than 95% of all stocks globallySignificant
Levered free cash flow (USD): -2,273,799,494.758Global P5: -209,298,741.335
Market cap is $15.55B, above the global median of $1.18BNotable
Market cap (USD): 15,551,221,997.515Global Median: 1,179,398,897.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Zhejiang Juhua Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Solventum Corporation
Tier 1ProductionThroughput-Bound ConversionRule
Fabrinet
Tier 1ProductionThroughput-Bound ConversionFlowRule
Coloplast A/S Class B
Tier 1ProductionThroughput-Bound ConversionRule
Bharat Heavy Electricals Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Albemarle Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Hanmi Semiconductor Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
SK Innovation Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Lincoln Electric Holdings Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Lenovo Group Limited
Tier 1ProductionThroughput-Bound ConversionFlowInterface
Companies that share active interpretations — structural patterns currently present in both stocks.
Anbio Biotechnology Limited
1 interpretationClose Below 40W SMA With Profitability
Parsons Corporation
1 interpretationClose Below 40W SMA With Profitability
Portillo's Inc.
1 interpretationClose Below 40W SMA With Profitability